<?xml version="1.0" encoding="UTF-8"?>
<svg height="735.1" width="4165.7" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.57,0.53,0.4,0.54,0.34,0.47,0.24,0.53,0.47,0.53,0.54,0.32,0.55,0.47,0.3,0.3,0.47,0.43,0.32,0.55,0.54,0.3,0.55,0.59,0.43,0.49,0.69,0.55,0.54,0.54,0.55,0.53,0.54,0.34,0.32,0.53,0.55,0.54,0.34,0.47,0.24,0.54,0.43,0.54,0.54,0.53,0.32,0.47,0.54,0.55,0.72,0.24,0.32,0.54" y="329.3" x="56.7,62.0,66.8,70.5,75.5,78.6,82.9,85.1,90.0,94.3,99.3,104.3,107.2,110.0,114.3,117.1,119.9,124.2,128.1,131.1,133.9,138.9,141.6,144.5,149.9,153.8,158.3,164.7,167.4,172.4,177.4,180.2,185.1,190.0,193.2,196.2,201.0,203.9,208.8,212.0,216.3,218.5,223.5,227.4,232.4,237.4,242.3,245.2,249.5,254.5,257.4,264.0,266.2,269.2" style="fill:rgb(19,20,19);font-family:LywycdAdvTT83913201.I;font-size:9.2px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Vasorelaxant effect of AcEO on aorta preincubated with</text>
  <text svgx:width="0.54,0.54,0.32,0.53,0.4,0.4,0.24,0.54,0.81,0.55,0.43,0.54,0.53,0.54,0.54,0.47,0.24,0.4,0.55,0.54,0.24,0.54,0.43,0.49,0.47,0.34,0.4,0.23,0.55,0.5,0.49,0.59,0.23,0.55,0.51,0.31,0.59,0.53,0.23,0.55,0.55,0.53,0.56,0.24,0.51,0.55,0.53,0.54,0.54" y="341.3" x="56.7,61.7,66.6,69.6,74.5,78.1,81.8,84.0,88.9,96.4,99.3,103.2,108.2,113.1,118.0,123.0,127.3,129.5,133.2,136.0,141.0,143.2,148.2,152.1,156.6,160.9,164.0,167.7,169.8,172.6,177.2,181.7,187.2,189.3,192.1,196.8,199.6,205.2,210.1,212.2,214.9,220.0,224.9,230.1,232.3,236.9,239.8,244.6,249.6" style="fill:rgb(19,20,19);font-family:LywycdAdvTT83913201.I;font-size:9.2px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">potassium channels blockers, TEA, 4-AP, BaCl2 and</text>
  <text svgx:width="0.64,0.24,0.47,0.54,0.47,0.54,0.43,0.24,0.53,0.81,0.24,0.54,0.47" y="353.3" x="56.7,62.6,64.8,69.1,74.1,78.4,83.4,87.4,89.6,94.5,102.0,104.2,109.2" style="fill:rgb(19,20,19);font-family:LywycdAdvTT83913201.I;font-size:9.2px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Glybenclamide</text>
  <text svgx:width="0.56,0.38,0.45,0.32,0.38,0.45,0.45,0.32,0.83,0.45,0.55,0.32,0.55,0.52,0.29,0.55,0.45,0.52,0.38,0.32,0.45,0.55,0.7,0.26,0.32,0.54,0.55,0.53,0.52,0.32,0.45,0.38,0.38,0.26,0.54,0.83,0.55,0.45,0.54,0.45,0.55,0.55,0.45,0.26,0.38,0.55,0.52,0.26,0.52,0.45,0.5,0.45,0.38,0.38,0.22" y="365.3" x="56.7,62.2,65.9,70.3,73.4,77.1,81.5,85.9,89.1,97.3,101.6,107.1,110.2,113.7,118.8,121.6,125.0,129.4,134.5,138.2,141.3,145.7,149.1,155.9,158.5,161.6,166.9,170.4,175.6,180.7,183.9,188.4,192.2,195.9,198.5,203.8,211.9,215.4,219.8,225.1,229.4,234.9,240.3,244.7,247.3,251.0,254.4,259.5,262.1,267.2,271.6,276.6,280.9,284.6,288.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pretreatment of aorta with potassium channels blockers;</text>
  <text svgx:width="0.67,0.56,0.71,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.55,0.5,0.5,0.22" y="377.3" x="56.7,63.3,69.2,76.1,82.7,86.0,91.0,96.0,98.2,103.2,108.2,117.1,122.8,124.8,129.9,132.0,138.6,143.6,148.6" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">TEA (98.91%± 3, 73;</text>
  <text svgx:width="0.52" y="377.3" x="157.4" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.22,0.55,0.5,0.36,0.71,0.56,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="377.3" x="164.6,169.9,171.9,176.9,179.1,184.1,189.1,192.4,194.5,201.1,206.2,209.7,216.9,222.4,229.0,232.2,237.3,242.3,244.5,249.5,254.6,263.4,269.1,271.2,276.2,278.4,283.4,288.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&gt; 0.05), 4-AP (98.05%± 2.96;</text>
  <text svgx:width="0.52" y="389.3" x="56.7" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.22,0.55,0.59,0.45,0.68,0.26" y="389.3" x="63.8,69.1,71.2,76.2,78.4,83.5,88.4,91.7,93.8,99.0,104.9,109.2,115.8" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&gt; 0.05), BaCl</text>
  <text svgx:width="0.5" y="391.0" x="118.2" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:6.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.32,0.5,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22,0.55,0.53,0.55,0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.55,0.45,0.55,0.53,0.55,0.48,0.26,0.45,0.52,0.45,0.55,0.45,0.26,0.45,0.36" y="389.3" x="125.6,128.8,133.5,138.4,143.2,145.3,150.1,155.0,163.6,169.2,171.2,176.1,178.0,182.9,187.7,189.8,193.6,198.7,200.6,205.9,207.8,212.7,214.7,219.6,224.3,227.5,231.3,235.6,240.9,246.1,249.8,254.5,256.9,261.3,266.2,270.6,275.9,280.2,282.7,287.1" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(103.52%± 2.47; p &gt; 0.05) and glybencla-</text>
  <text svgx:width="0.83,0.26,0.53,0.45,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="401.3" x="56.7,64.9,67.2,72.4,76.9,84.2,87.3,92.1,97.0,98.9,103.8,108.6,117.3,123.0,124.8,129.7,131.8,136.7,141.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mide (99.55%± 2.66;</text>
  <text svgx:width="0.52" y="401.3" x="150.9" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.22,0.55,0.38,0.54,0.52,0.7,0.45,0.53,0.55,0.55,0.52,0.55,0.38,0.26,0.48,0.55,0.26,0.29,0.26,0.45,0.45,0.55,0.32" y="401.3" x="157.9,163.2,165.0,169.9,171.9,176.8,181.5,184.7,186.8,194.2,197.9,203.1,208.2,214.9,219.2,224.4,231.8,237.2,242.3,249.6,253.4,255.8,260.5,265.7,268.2,271.0,273.4,277.8,282.0,287.5" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&gt; 0.05), showed no significant</text>
  <text svgx:width="0.45,0.54,0.45,0.55,0.48,0.45,0.38,0.55,0.26,0.55,0.55,0.71,0.45,0.56,0.78,0.55,0.32,0.5,0.22,0.5" y="413.3" x="56.7,61.1,66.2,70.6,75.9,80.6,84.8,88.5,91.6,94.1,99.5,102.4,109.2,113.6,118.9,126.6,129.6,132.8,137.5,139.7" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">changes in AcEO (0.1</text>
  <text svgx:width="0.6" y="413.3" x="144.4" style="fill:rgb(19,20,19);font-family:PcsvrmAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text svgx:width="0.5,0.5,0.5" y="413.3" x="150.2,155.1,159.9" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">100</text>
  <text svgx:width="0.54" y="413.3" x="167.8" style="fill:rgb(19,20,19);font-family:YcgjmgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">μ</text>
  <text svgx:width="0.48,0.36,0.83,0.26,0.32,0.55,0.26,0.55,0.53,0.54,0.45,0.45,0.53,0.36,0.46,0.45,0.38,0.52,0.38,0.45,0.26,0.45,0.49,0.45,0.32,0.26,0.52,0.55" y="413.3" x="173.0,177.7,181.1,189.2,191.7,194.9,197.9,200.3,205.7,210.8,216.1,220.3,224.7,229.7,233.3,237.7,242.0,245.7,250.8,254.3,258.7,261.1,265.5,270.3,274.6,277.7,280.1,285.1" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">g/ml) induced-vasorelaxation</text>
  <text svgx:width="0.32,0.52,0.26,0.48,0.22,0.55,0.5,0.45,0.32,0.22" y="425.3" x="56.7,59.8,64.8,67.2,71.9,74.1,76.6,81.5,85.7,88.9" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(Fig. 6a).</text>
  <text svgx:width="0.57,0.53,0.4,0.54,0.34,0.47,0.24,0.53,0.47,0.53,0.54,0.32,0.55,0.47,0.3,0.3,0.47,0.43,0.32,0.55,0.54,0.3,0.55,0.59,0.43,0.49,0.69,0.55,0.54,0.54,0.55,0.53,0.54,0.34,0.32,0.53,0.55,0.54,0.34,0.47,0.24,0.54,0.43,0.54,0.54,0.53,0.32,0.47,0.54,0.55,0.72,0.24,0.32,0.54" y="329.3" x="304.7,310.0,314.9,318.5,323.5,326.6,330.9,333.1,338.0,342.3,347.4,352.3,355.3,358.1,362.4,365.2,367.9,372.2,376.2,379.1,381.9,386.9,389.7,392.5,397.9,401.9,406.4,412.7,415.4,420.4,425.4,428.2,433.1,438.1,441.2,444.2,449.1,451.9,456.9,460.0,464.3,466.5,471.5,475.4,480.4,485.4,490.3,493.2,497.6,502.5,505.4,512.0,514.2,517.2" style="fill:rgb(19,20,19);font-family:LywycdAdvTT83913201.I;font-size:9.2px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Vasorelaxant effect of AcEO on aorta preincubated with</text>
  <text svgx:width="0.25,0.54,0.54,0.54,0.81,0.47,0.32,0.54,0.53,0.43,0.24,0.54,0.23,0.55,0.5,0.54,0.53,0.54,0.4,0.24,0.54,0.53,0.34,0.54,0.24,0.54,0.55,0.53,0.54,0.54,0.55,0.57,0.47,0.34,0.53,0.54,0.53,0.81,0.24,0.24" y="341.3" x="304.7,307.0,312.0,317.0,322.0,329.4,333.7,336.7,341.7,346.7,350.6,352.8,357.8,359.9,362.7,367.3,372.2,377.1,382.1,385.7,387.9,392.9,397.8,401.0,405.9,408.2,413.2,416.0,420.9,425.9,430.8,433.6,438.9,443.2,446.4,451.3,456.2,461.1,468.6,470.8" style="fill:rgb(19,20,19);font-family:LywycdAdvTT83913201.I;font-size:9.2px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Indomethacin, Thapsigargin and Verapamil</text>
  <text svgx:width="0.56,0.38,0.45,0.32,0.38,0.45,0.45,0.32,0.83,0.45,0.55,0.32,0.55,0.52,0.29,0.55,0.45,0.52,0.38,0.32,0.45,0.55,0.7,0.26,0.32,0.54,0.55,0.45,0.45,0.45,0.26,0.52,0.52,0.49,0.45,0.48,0.45,0.55,0.45,0.38,0.45,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.52,0.38,0.22" y="353.3" x="304.7,310.2,313.9,318.3,321.4,325.1,329.5,334.0,337.1,345.3,349.7,355.1,358.2,365.0,370.1,373.0,379.7,384.1,389.2,392.9,396.0,400.4,407.2,414.1,416.6,419.8,425.1,431.8,436.2,440.6,445.0,447.5,452.6,457.7,462.6,467.0,471.7,476.1,481.5,486.0,489.8,494.2,500.9,503.5,508.9,514.2,516.7,521.8,524.4,527.6,532.7,536.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pretreatment of aorta with cyclooxygenase inhibitor;</text>
  <text svgx:width="0.26,0.55,0.53,0.52,0.83,0.45,0.32,0.54,0.45,0.45,0.26,0.55,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="365.3" x="304.7,307.3,312.7,317.9,323.0,331.1,335.6,338.8,344.1,348.5,352.8,355.4,360.8,365.4,368.6,373.5,378.4,380.5,385.5,390.4,399.2,404.9,406.9,411.8,413.9,418.8,423.7" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">indomethacin (92.95%± 2.73;</text>
  <text svgx:width="0.52" y="365.3" x="430.5" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.55,0.53,0.26,0.53,0.55,0.55,0.52,0.32,0.55,0.53,0.38,0.52,0.53,0.54,0.45,0.45" y="365.3" x="437.5,442.8,444.8,449.7,451.8,456.7,461.6,464.7,469.4,474.6,477.2,482.4,486.9,492.3,497.4,500.6,505.2,510.5,514.1,519.2,524.4,529.7,534.1" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&gt; 0.05) did not produce</text>
  <text svgx:width="0.45,0.55,0.45,0.55,0.38,0.26,0.48,0.55,0.26,0.29,0.26,0.45,0.45,0.55,0.32,0.55,0.53,0.26,0.29,0.29,0.45,0.38,0.45,0.55,0.45,0.45,0.55,0.52,0.29,0.55,0.46,0.45,0.38,0.52,0.38,0.45,0.26,0.45,0.49,0.45,0.32,0.26,0.52,0.55,0.55,0.26,0.55,0.53,0.54,0.45,0.45,0.53,0.55,0.52,0.45" y="377.3" x="304.7,309.1,314.5,318.9,323.7,327.5,330.0,334.7,340.2,342.8,345.6,348.2,352.5,356.9,362.3,365.5,370.4,375.6,378.1,381.0,383.8,388.2,391.9,396.3,401.8,406.2,410.6,415.3,420.4,423.3,428.4,432.9,437.4,441.2,446.3,450.0,454.4,457.0,461.5,466.3,470.7,473.8,476.4,481.5,486.8,491.8,494.3,499.7,504.9,510.2,514.6,519.0,524.2,529.1,534.2" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">any significant difference of vasorelaxation induced by</text>
  <text svgx:width="0.71,0.45,0.56,0.78,0.55,0.53,0.38,0.45,0.45,0.52,0.55,0.32,0.38,0.45,0.45,0.32,0.45,0.53,0.55,0.7,0.26,0.32,0.54,0.55,0.53,0.54,0.45,0.55,0.45,0.26,0.45,0.53,0.54,0.38,0.26,0.55,0.45,0.22,0.55,0.67,0.54,0.45,0.38,0.45,0.29,0.52,0.38,0.45,0.22" y="389.3" x="304.7,311.7,316.0,321.6,329.2,337.2,342.4,346.0,350.5,354.9,360.0,365.4,368.6,372.3,376.7,381.1,384.3,388.6,393.8,401.8,408.7,411.2,414.4,419.7,427.7,433.0,438.3,442.6,448.0,452.4,455.0,459.4,464.6,470.0,473.7,476.2,481.6,486.0,488.2,496.1,502.6,508.0,512.3,516.0,520.4,523.2,528.3,532.0,536.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">AcEO precontracted with phenylephrine. Therefore,</text>
  <text svgx:width="0.45,0.52,0.38,0.32,0.45,0.55,0.53,0.38,0.45,0.26,0.55,0.45,0.54,0.52,0.45,0.32,0.45,0.53,0.55,0.7,0.26,0.32,0.54,0.55,0.45,0.55,0.53,0.52,0.53,0.26,0.45,0.38,0.83,0.26,0.45,0.55,0.38,0.45,0.32,0.26,0.45,0.54,0.26,0.54,0.83,0.55,0.45,0.45,0.26,0.45,0.26,0.54,0.83,0.36" y="401.3" x="304.7,309.1,314.2,317.9,321.0,325.4,328.6,333.8,337.5,341.9,344.4,349.8,354.3,359.6,364.7,369.1,372.3,376.7,381.9,385.0,391.8,394.4,397.5,402.8,406.0,410.4,415.8,421.0,426.1,431.3,433.9,438.5,442.2,450.4,452.9,457.4,460.5,464.2,468.6,471.7,474.3,478.7,484.0,486.5,491.8,499.9,503.2,507.6,512.0,514.5,518.9,521.4,526.7,535.0" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">aorta preincubated with endoplasmic reticulum calcium-</text>
  <text svgx:width="0.71,0.67,0.56,0.45,0.38,0.45,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.52,0.38,0.22,0.55,0.32,0.54,0.45,0.53,0.38,0.26,0.48,0.45,0.38,0.48,0.26,0.55,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="413.3" x="304.7,311.1,317.6,323.1,327.6,331.4,335.8,339.1,341.7,347.1,352.4,354.9,360.0,362.6,365.8,370.9,374.6,376.8,380.1,383.3,388.6,393.0,398.2,401.9,404.5,409.2,413.7,417.4,422.1,424.6,430.0,433.4,436.5,441.4,446.3,448.5,453.4,458.3,467.2,472.8,474.8,479.7,481.8,486.7,491.6" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ATPase inhibitor; thapsigargin (45.34%± 6.58;</text>
  <text svgx:width="0.52" y="413.3" x="497.1" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.5,0.32,0.22" y="413.3" x="504.2,509.5,511.5,516.4,518.5,523.4,528.3,533.2,536.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&lt; 0.001),</text>
  <text svgx:width="0.45,0.55,0.53,0.55,0.45,0.45,0.26,0.45,0.26,0.54,0.83,0.55,0.45,0.54,0.45,0.55,0.55,0.45,0.26,0.55,0.32,0.45,0.53,0.45,0.55,0.69,0.78,0.68,0.55,0.52,0.26,0.52,0.45,0.5,0.45,0.38,0.22,0.55,0.46,0.45,0.38,0.45,0.53,0.45,0.83,0.26,0.26" y="425.3" x="304.7,309.1,314.5,319.7,327.3,331.7,336.1,338.6,343.0,345.5,350.9,359.1,366.6,371.0,376.3,380.7,386.1,391.5,395.9,398.4,406.0,409.2,413.6,418.8,423.2,430.2,437.0,444.6,451.3,458.9,464.0,466.5,471.6,476.0,480.9,485.3,489.0,491.1,498.7,503.2,507.5,511.2,515.7,520.9,525.3,533.4,536.0" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and calcium channel type VOC blocker; verapamil</text>
  <text class="image" id="image.7.1" width="283" height="172" y="104.0" x="155.7" style="font-size:8.0px;">image.7.1.156_440.104_277</text>
  <text svgx:width="0.52,0.27,0.58,0.25,0.55,0.55" y="279.7" x="62.7,66.9,69.0,73.7,75.7,78.1" style="fill:rgb(19,20,19);font-family:GyswgcAdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Fig. 3</text>
  <text svgx:width="0.58,0.53,0.3,0.21,0.53,0.43,0.21,0.54,0.45,0.53,0.3,0.55,0.48,0.26,0.26,0.48,0.44,0.3,0.55,0.53,0.26" y="279.7" x="84.9,89.4,93.7,95.9,97.5,101.6,105.0,106.5,110.8,114.2,118.4,120.8,122.8,126.6,128.5,130.6,134.2,137.7,140.1,142.1,146.4" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Antioxidant effect of</text>
  <text svgx:width="0.53,0.18,0.41,0.5,0.79,0.5,0.42,0.34,0.29,0.28,0.2,0.34" y="279.7" x="150.4,154.7,155.9,159.0,163.0,169.1,173.1,176.2,178.9,181.1,183.3,184.8" style="fill:rgb(19,20,19);font-family:WqcrxnAdvTT1b53b5fb.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">A.campestris</text>
  <text svgx:width="0.45,0.17,0.55,0.48,0.36,0.36,0.48,0.53,0.3,0.21,0.45,0.21,0.55,0.53,0.21,0.21,0.55,0.26,0.58,0.44,0.46,0.67,0.26,0.55,0.45,0.53,0.54,0.55,0.45,0.36,0.44,0.53,0.29,0.54,0.21,0.44,0.55,0.45,0.44,0.21,0.54,0.55,0.53,0.53,0.55,0.26" y="279.7" x="189.5,193.1,194.5,196.4,200.3,203.0,205.9,209.5,213.8,216.0,217.7,221.0,222.7,224.8,229.0,230.5,232.2,234.3,236.3,240.8,244.3,247.7,253.0,255.0,257.1,260.7,264.8,269.1,271.1,274.7,277.5,280.8,285.0,287.2,291.5,293.0,296.5,298.5,302.1,305.5,307.1,311.4,313.4,317.6,321.9,323.9" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. essential oil (AcEO) and ascorbic acid on (</text>
  <text svgx:width="0.5" y="279.7" x="325.9" style="fill:rgb(19,20,19);font-family:RstdxkAdvTT99c4c969;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">a</text>
  <text svgx:width="0.26,0.55,0.3,0.53,0.48,0.55,0.36,0.44,0.45,0.45,0.48,0.53,0.54,0.21,0.53,0.54,0.55,0.53,0.26,0.55,0.48,0.17,0.55,0.48,0.26,0.54,0.21,0.54,0.53,0.48,0.53,0.44,0.21,0.29,0.48,0.29,0.54,0.21,0.44,0.29,0.44,0.53,0.44,0.54,0.29,0.45,0.4,0.44,0.21,0.55,0.26,0.64,0.5,0.5,0.63,0.26,0.55,0.29,0.45,0.54,0.21,0.44,0.45,0.21" y="279.7" x="329.7,331.8,333.9,336.2,340.4,344.3,346.2,349.1,352.5,356.0,359.4,363.3,367.3,371.5,373.2,377.2,381.6,383.6,387.9,390.0,391.9,395.7,397.1,399.1,402.9,404.8,409.1,410.6,414.9,419.0,422.8,426.8,430.3,431.8,434.0,437.9,440.0,444.3,445.8,449.3,451.4,454.9,459.0,462.5,466.6,468.8,472.3,475.5,478.8,480.5,482.5,484.6,489.6,493.5,497.5,502.2,504.3,506.4,508.6,512.1,516.4,517.9,521.4,524.8" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">) the scavenging of 2, 2(diphenyl-1-picryhydrazyl (DPPH) radical</text>
  <text svgx:width="0.26" y="289.6" x="62.7" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(</text>
  <text svgx:width="0.58" y="289.6" x="64.7" style="fill:rgb(19,20,19);font-family:RstdxkAdvTT99c4c969;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">b</text>
  <text svgx:width="0.26,0.55,0.3,0.53,0.48,0.55,0.54,0.29,0.48,0.45,0.48,0.53,0.3,0.21,0.53,0.53,0.55,0.53,0.26" y="289.6" x="69.2,71.3,73.4,75.8,79.9,83.7,85.7,90.0,92.2,96.0,99.4,103.3,107.3,109.7,111.2,115.4,119.7,121.7,125.9" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">) the prevention of</text>
  <text svgx:width="0.54" y="289.6" x="129.9" style="fill:rgb(19,20,19);font-family:YjgyvcAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">β</text>
  <text svgx:width="0.29,0.44,0.45,0.29,0.53,0.3,0.48,0.53,0.48,0.55,0.54,0.21,0.48,0.45,0.44,0.53,0.21,0.53,0.54,0.55,0.45,0.53,0.54,0.17,0.55,0.5,0.45,0.21,0.52,0.48,0.36,0.55,0.45,0.29,0.48,0.55,0.81,0.48,0.45,0.53,0.55,0.59,0.55,0.46,0.46,0.77,0.17" y="289.6" x="134.2,136.4,139.9,143.3,145.6,149.7,152.1,155.7,160.0,163.8,165.8,170.0,171.6,175.3,178.8,182.2,186.3,188.0,192.0,196.3,198.4,201.9,206.1,210.3,211.6,213.7,217.7,221.0,222.7,226.7,230.4,233.3,235.4,239.0,241.1,245.0,247.0,253.5,257.1,260.7,264.9,266.3,271.1,272.6,276.1,279.8,285.7" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-carotene bleaching and; Values are mean ± SEM,</text>
  <text svgx:width="0.51" y="289.6" x="289.1" style="fill:rgb(19,20,19);font-family:WqcrxnAdvTT1b53b5fb.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">n</text>
  <text svgx:width="0.59,0.55,0.48,0.17,0.55,0.45,0.53,0.54,0.55,0.45,0.53,0.45,0.21,0.44,0.4,0.48,0.54,0.55,0.72,0.21,0.3,0.53,0.55,0.21,0.21,0.53,0.48,0.45,0.29,0.55,0.29,0.48,0.54,0.29,0.48,0.36,0.36,0.21,0.53,0.53,0.55,0.3,0.48,0.36,0.3" y="289.6" x="294.7,299.4,300.9,304.8,306.1,308.1,311.5,315.8,320.1,322.1,325.5,329.8,333.2,334.8,338.2,341.3,344.9,349.2,351.3,357.1,358.5,360.9,365.2,367.2,368.7,370.4,374.5,378.3,381.7,384.0,386.1,388.3,392.1,396.3,398.5,402.3,405.1,407.8,409.5,413.6,417.8,419.9,422.3,425.9,428.8" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">= 3, and analyzed with linear regression test</text>
  <text class="image" id="image.7.2" width="340" height="239" y="462.9" x="127.3" style="font-size:8.0px;">image.7.2.127_468.463_702</text>
  <text svgx:width="0.52,0.27,0.58,0.25,0.55,0.55" y="705.1" x="62.7,66.9,69.0,73.7,75.7,78.1" style="fill:rgb(19,20,19);font-family:GyswgcAdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Fig. 4</text>
  <text svgx:width="0.46,0.53,0.48,0.55,0.53,0.29,0.21,0.54,0.21,0.53,0.45,0.21,0.3,0.29,0.44,0.21,0.53,0.54,0.55,0.45,0.53,0.54,0.55,0.54,0.48,0.29,0.44,0.48,0.53,0.3,0.45,0.54,0.48,0.55,0.53,0.26,0.55,0.45,0.54,0.54,0.29,0.48,0.54,0.45,0.3,0.21,0.53,0.53,0.55,0.21,0.53,0.53,0.21,0.54,0.21,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.48,0.17,0.48,0.17,0.55,0.48,0.17,0.48,0.55,0.45,0.53,0.54,0.55,0.48,0.55,0.81,0.54,0.34,0.81,0.21,0.55,0.53,0.26" y="705.1" x="84.9,88.5,92.6,96.4,98.5,102.7,104.8,106.5,110.7,112.2,116.4,119.8,121.5,123.7,126.0,129.4,131.0,135.1,139.4,141.4,145.0,149.1,153.4,155.5,159.7,163.5,165.7,169.2,172.8,177.0,179.3,182.8,187.0,190.8,192.9,197.1,199.2,201.1,204.7,208.9,213.1,215.4,219.1,223.4,226.8,229.2,230.7,234.9,239.2,241.1,242.8,246.8,251.1,252.6,256.9,258.3,260.8,262.3,266.5,270.7,272.7,276.9,279.0,281.0,284.7,286.0,289.7,291.1,293.1,296.9,298.1,301.9,304.0,307.4,311.7,316.0,318.0,321.8,323.9,330.4,334.5,337.2,343.6,345.2,347.2,351.5" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">The originaltrcing and percentage of aggregation inhibition of 0.1, 0.5 and 1 mg/ml of</text>
  <text svgx:width="0.53,0.18,0.55,0.41,0.5,0.79,0.5,0.42,0.34,0.29,0.28,0.2,0.34" y="705.1" x="355.6,359.8,361.3,363.2,366.2,370.2,376.4,380.4,383.5,386.1,388.5,390.6,392.1" style="fill:rgb(19,20,19);font-family:WqcrxnAdvTT1b53b5fb.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">A. campestris</text>
  <text svgx:width="0.45,0.17,0.55,0.48,0.36,0.36,0.48,0.53,0.3,0.21,0.45,0.21,0.55,0.53,0.21,0.21,0.55,0.26,0.58,0.44,0.46,0.67,0.26,0.55,0.53,0.53,0.55,0.3,0.53,0.29,0.53,0.81,0.54,0.21,0.53,0.55,0.26" y="705.1" x="396.8,400.3,401.7,403.7,407.5,410.3,413.1,416.9,420.9,423.4,424.9,428.3,430.0,432.1,436.3,437.8,439.5,441.5,443.6,448.0,451.5,455.0,460.2,462.3,464.4,468.7,472.9,474.9,477.3,481.3,483.5,487.8,494.1,498.4,499.9,504.2,506.2" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. essential oil (AcEO) on thrombin (</text>
  <text svgx:width="0.5" y="705.1" x="508.2" style="fill:rgb(19,20,19);font-family:RstdxkAdvTT99c4c969;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">a</text>
  <text svgx:width="0.26,0.55,0.45,0.53,0.54" y="705.1" x="512.1,514.2,516.2,519.7,523.9" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">) and</text>
  <text svgx:width="0.58,0.64,0.5,0.55,0.26" y="715.1" x="62.7,67.2,72.4,76.4,78.3" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ADP (</text>
  <text svgx:width="0.58" y="715.1" x="80.3" style="fill:rgb(19,20,19);font-family:RstdxkAdvTT99c4c969;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">b</text>
  <text svgx:width="0.26,0.55,0.21,0.53,0.54,0.52,0.44,0.48,0.54,0.55,0.54,0.21,0.45,0.3,0.48,0.21,0.48,0.3,0.55,0.45,0.54,0.54,0.29,0.48,0.54,0.45,0.3,0.21,0.53,0.53,0.17,0.55,0.5,0.45,0.21,0.52,0.48,0.36,0.55,0.45,0.29,0.48,0.55,0.81,0.48,0.45,0.53,0.55,0.59,0.55,0.46,0.46,0.77,0.17" y="715.1" x="84.9,87.0,89.1,90.7,94.8,99.0,103.1,106.5,110.3,114.6,116.6,120.8,122.5,125.9,128.3,131.9,133.6,137.3,139.7,141.7,145.2,149.5,153.6,156.0,159.6,163.9,167.3,169.7,171.2,175.5,179.5,180.8,182.9,186.9,190.3,191.8,196.0,199.7,202.6,204.6,208.2,210.3,214.2,216.2,222.7,226.4,229.8,234.1,235.6,240.3,241.8,245.5,248.9,255.1" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">) induced platelet aggregation. Values are mean ± SEM,</text>
  <text svgx:width="0.51" y="715.1" x="258.3" style="fill:rgb(19,20,19);font-family:WqcrxnAdvTT1b53b5fb.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">n</text>
  <text svgx:width="0.59,0.55,0.48,0.17,0.55,0.45,0.53,0.45,0.21,0.44,0.36,0.48,0.54,0.55,0.72,0.21,0.3,0.53,0.55,0.53,0.53,0.48,0.55,0.72,0.45,0.44,0.55,0.58,0.63,0.67,0.5,0.58,0.55,0.26,0.53,0.21,0.21,0.53,0.72,0.48,0.54,0.55,0.54,0.44,0.55,0.5,0.53,0.53,0.26,0.48,0.29,0.29,0.53,0.53,0.21" y="715.1" x="264.0,268.7,270.1,274.0,275.3,277.3,280.7,285.0,288.4,290.1,293.4,296.2,300.0,304.3,306.3,311.9,313.6,315.8,320.1,322.1,326.4,330.5,334.3,336.3,342.0,345.4,348.9,351.0,355.6,360.6,365.8,369.8,374.4,376.4,378.5,382.5,384.2,385.7,389.9,395.4,399.3,403.6,405.6,409.9,413.4,415.4,419.2,423.5,427.6,429.7,433.2,435.6,437.7,442.0,446.1" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">= 6, analysed with one way ANOVA followed by Bonferroni</text>
  <text svgx:width="0.17" y="715.1" x="447.6" style="fill:rgb(19,20,19);font-family:PmpdftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">’</text>
  <text svgx:width="0.36,0.55,0.54,0.53,0.36,0.3,0.29,0.3,0.48,0.36,0.3,0.17" y="715.1" x="448.8,451.7,453.8,458.2,462.2,465.0,467.4,469.6,472.0,475.6,478.5,480.8" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">s post-test;</text>
  <text svgx:width="0.5" y="715.1" x="484.2" style="fill:rgb(19,20,19);font-family:WqcrxnAdvTT1b53b5fb.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.38,0.55,0.59,0.55,0.48,0.17,0.48,0.48,0.48,0.55,0.45,0.36" y="715.1" x="488.1,491.1,492.6,497.3,498.8,502.7,503.8,507.5,511.3,515.2,517.1,520.7" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">* &lt; 0.005 vs</text>
  <text svgx:width="0.44,0.53,0.53,0.3,0.29,0.53,0.21,0.55,0.45,0.53,0.54,0.55,0.38,0.38,0.55,0.59,0.55,0.48,0.17,0.48,0.48,0.55,0.45,0.36,0.55,0.44,0.53,0.53,0.3,0.29,0.53,0.21" y="725.1" x="62.7,66.2,70.2,74.5,76.7,78.9,83.2,84.8,86.8,90.4,94.5,98.8,100.9,103.8,106.8,108.4,113.1,114.6,118.4,119.6,123.4,127.2,129.2,132.7,135.5,137.6,141.1,145.2,149.4,151.7,154.0,158.1" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">control and ** &lt; 0.01 vs control</text>
  <text svgx:width="0.66,0.23,0.56" y="39.0" x="56.7,61.9,63.8" style="fill:rgb(19,20,19);font-family:NjjblyAdvTTe45e47d2;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Dib</text>
  <text svgx:width="0.45,0.31,0.55,0.52,0.22,0.21,0.55,0.51,0.77,0.55,0.55,0.55,0.52,0.8,0.52,0.22,0.45,0.8,0.45,0.53,0.31,0.52,0.31,0.44,0.55,0.52,0.53,0.52,0.55,0.56,0.22,0.31,0.45,0.31,0.53,0.52,0.31,0.22,0.45,0.45,0.55,0.77,0.45,0.52,0.22,0.42,0.22,0.53,0.45" y="39.0" x="70.6,74.2,76.7,79.1,83.2,85.0,86.7,89.1,93.1,99.3,103.7,106.1,110.5,114.6,121.1,125.2,127.0,130.5,137.0,140.5,144.8,147.2,151.3,153.8,157.4,159.8,163.9,168.2,172.3,174.7,179.2,180.9,183.4,187.0,189.5,193.7,197.9,200.4,202.1,205.7,209.3,211.6,217.8,221.4,225.5,227.3,230.6,232.3,236.6" style="fill:rgb(19,20,19);font-family:GnxlbsAdvTT7329fd89.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al. BMC Complementary and Alternative Medicine</text>
  <text svgx:width="0.21,0.28,0.51,0.51,0.51,0.51,0.28,0.21,0.51,0.51,0.21,0.51,0.51,0.21" y="39.0" x="242.5,244.2,246.5,250.6,254.7,258.8,262.9,265.2,266.9,271.0,275.1,276.7,280.9,285.0" style="fill:rgb(19,20,19);font-family:MyriadPro-Regular;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> (2017) 17:82 </text>
  <text svgx:width="0.53,0.48,0.55,0.5,0.55,0.51,0.55,0.54,0.29,0.55,0.51,0.51" y="39.0" x="496.1,500.3,504.1,508.6,512.6,514.9,519.0,521.4,525.7,528.1,530.4,534.5" style="fill:rgb(19,20,19);font-family:NjjblyAdvTTe45e47d2;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Page 7 of 15</text>
 </g>
</svg>
